Dr. Rodolfo A Munera, MD Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1001 Clifton Ave Ste 1b, Clifton, NJ 07013 Phone: 973-472-8000 |
Dr. Frederick Okoye Jr., MD Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 642 Broad St, Clifton, NJ 07013 Phone: 973-249-1855 Fax: 973-249-1856 |
Dr. Jakaulla Khan, MD Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1003 Main Ave, Clifton, NJ 07011 Phone: 973-777-9595 |
Dr. Sessine Najjar, M.D. Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 975 Clifton Ave, Clifton, NJ 07013 Phone: 973-778-8666 Fax: 973-778-7559 |
Dr. Nimit Nitin Saraiya, M.D. Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 17 Pilgrim Dr, Clifton, NJ 07013 Phone: 732-857-0234 |
Dr. Yasmeen Sultana, MD Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 11 Godwin Pl, Clifton, NJ 07013 Phone: 201-563-5651 |
Sabah Varoqua, M.D. Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 975 Clifton Ave, Clifton, NJ 07013 Phone: 973-778-8666 Fax: 973-778-7559 |
News Archive
Team of researchers led by Professor Richard Gordon and Associate Professor Michael Stowasser has found primary aldosteronism (PAL) , a type of high blood pressure that can be cured by surgery , to be ten times more common than was previously suspected.
In a study published yesterday in the scientific journal Nature Immunology, a group at the La Jolla Institute (LJI) led by Pandurangan Vijayanand, Ph.D. identify new genes that likely contribute to asthma, a disease that currently affects over 200 million people world wide.
Under a three-year extension of an existing relationship, Verizon Business will securely connect 16 key Eurofins laboratories and research centers in Europe, Asia and the U.S. with the company's global customer base.
When the covid-19 pandemic forced behavioral health providers to stop seeing patients in person and instead hold therapy sessions remotely, the switch produced an unintended, positive consequence: Fewer patients skipped appointments.
Shenzhen Beike Biotechnology Co. Ltd. ("Beike") and SiriCell Technologies, Inc. announced that they are ending their partnership in "Beike Holdings Limited", a joint venture formed by the two companies in 2008. Going forward, Beike will exit the joint venture, and all current and future Beike Holdings-initiated business activities will operate exclusively under the SiriCell brand. Beike Holdings was established to expand the availability of Beike's stem cell products outside of China through collaborative hospital partnerships and new international subsidiaries.
› Verified 5 days ago